Send us a Text Message.

Dr. Andrea Choe, MD, Ph.D. is the CEO and Co-Founder of Holoclara ( https://www.holoclara.com/ ), a company focused on creating novel, safe, orally bioavailable worm-derived therapeutics with a focus on indications such as allergies and autoimmune disorders.

While pursuing her doctorate at the California Institute of Technology, Dr. Choe uncovered a unique pheromone language shared by roundworms that may have evolved over hundreds of millions of years.

Dr. Choe’s research, including her discovery of novel molecules derived from worms that blocked formation of disease in animal models of allergic and autoimmune disease, has led to advances in the fields of evolutionary biology and extreme biology. Her work has become the foundation of Holoclara’s technology and mission to pioneer a new class of therapeutics that can provide relief for millions of people living with chronic and debilitating diseases.

Dr. Choe is a winner of the Emerging Women Founders in Biotech Award. She received her MD at USC Keck School of Medicine and her PhD at Caltech.

#CaenorhabditisElegans #WormDerivedTherapeutics #AutoimmuneDisease #Allergies #Nematodes #AndreaChoe #Holoclara #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research

Support the Show.

Send us a Text Message.

Dr. Abdulelah Alhawsawi, MD is the CEO of Novo Genomics ( https://novogenomics.sa/ ), a company located in KSA with a vision of being the regionally trusted, globally recognized biotech leader in the field of genomics & multiomics.

Dr. Alhawsawi is the former Founding Director General of the Saudi Patient Safety Center ( SPSC - https://www.spsc.gov.sa/English/Pages/Home.aspx ), and MOH Advisor on Patient Safety and was involved in the core efforts establishing SPSC as a WHO Collaborating Center for patient safety policies and strategies (1 of only 5 WHOcc worldwide in this field).

Dr. Alhawsawi is a consultant to several national and international quality and safety organizations and recently became a board member and Vice President of the Global Sepsis Alliance ( GSA - https://globalsepsisalliance.org/ ) as well as a Board member of Joint Commission Resources Board. He was part of the Expert Panel on the 3rd Global Patient Safety Challenge of the WHO and chaired the Organizing Committee for the 4th Global Ministerial Summit on Patient Safety in Jeddah, Saudi Arabia.

Dr. Alhawsawi has helped introduce Patient Safety as a G20 priority in the 2020 G20 of Saudi Arabia. Currently, Dr. Alhawsawi is part of the WHO’s Global Patient Safety Action Plan Taskforce and is a Global Ambassador of the G20 Health & Development Partnership ( https://g20healthpartnership.com/dr-abdulelah-alhawsawi/ ).

Dr. Alhawsawi holds a bachelor’s degree in Medicine from King Abdulaziz University, Jeddah, Saudi Arabia, is Dual board certified in transplant and hepato-biliary surgery (American – Canadian), and he completed his training in Mount Sinai School of Medicine, New York. He is a member of numerous medical societies and national quality committees.

#AbdulelahAlhawsawi #PatientSafety #SaudiArabia #PreventableHarm #Sepsis #AntimicrobialResistance #HealthDiplomacy #ScienceDiplomacy #NovoGenomics #Genomics #Multiomics #PersonalizeMedicine #Agrigenomics #Premarital #Prenatal #NewbornCare#HereditaryDiseases #Oncology#GeneticsCounseling
#ClinicalGenetics

Support the Show.

Send us a Text Message.

Dr. Vanúsia Nogueira, Ph.D. is Executive Director of The International Coffee Organization ( ICO - https://icocoffee.org/ ), an organization focused on strengthening the global coffee sector and promoting it’s sustainable expansion in a market-based environment for the benefit of all actors in the Global Coffee Value Chain.

Dr. Nogueira comes from a family of coffee producers, and started her career at PwC Consulting, where she was a partner and worked for 15 years. She started working directly with coffee in 2002, always focusing on niche markets.

Dr. Nogueira served as executive director at the Brazilian Specialty Coffee Association (BSCA) from 2007 through April 2022 and took over as Executive Director at the International Coffee Organization in May 2022.

Dr. Nogueira holds a Ph.D. in Administration/Marketing from Rosario National University in Argentina, a BS in Systems Engineering and Administration from Pontifical Catholic University of Rio de Janeiro (PUC-RJ) and MBAs and post-MBA focusing on Management, Marketing and Advanced Project Management from Fundação Getulio Vargas-Rio de Janeiro (FGV-RJ).

The ICO was established in 1963 under the aegis of the United Nations and following the approval of the first International Coffee Agreement in 1962. And is the only intergovernmental organization for coffee, bringing together exporting and importing Governments. It currently represents 93% of world coffee production and 63% of world consumption.

Important Link - The Center for Circular Economy in Coffee - https://www.circulareconomyincoffee.org/

#Coffee #InternationalCoffeeOrganization #CircularEconomy #ICO #Macroeconomics #CoffeeValueChain #VanusiaNogueira #MinasGerais #Brazil #Sustainability #Producers #Growers #UnitedNations #SpecialtyCoffee #Beverages #Tea #Cocoa #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research

Support the Show.